mRNA Vaccine Platform Shows Promise Against Pandemic Influenza Strains, Including H5N1 Medical Countermeasures April 26, 2026 …
CSL Seqirus Awarded Contract for Influenza A(H5N8) Candidate Vaccine Medical Countermeasures August 28, 2023 …
